Galera Therapeutics, Inc. (GRTX)
OTCMKTS · Delayed Price · Currency is USD
0.0430
-0.0020 (-4.44%)
Mar 5, 2026, 3:28 PM EST
Galera Therapeutics Market Cap
Galera Therapeutics has a market cap or net worth of $3.24 million as of March 5, 2026. Its market cap has increased by 8.59% in one year.
Market Cap
3.24M
Enterprise Value
152.40M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since November 7, 2019, Galera Therapeutics's market cap has decreased from 292.35M to 3.24M, a decrease of -98.89%. That is a compound annual growth rate of -50.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 3.24M | 95.45% |
| Dec 31, 2025 | 1.66M | -51.98% |
| Dec 31, 2024 | 3.46M | -56.28% |
| Dec 29, 2023 | 7.91M | -81.38% |
| Dec 30, 2022 | 42.47M | -65.01% |
| Dec 31, 2021 | 121.35M | -52.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioxytran | 4.75M |
| Enzon Pharmaceuticals | 4.46M |
| GPL Holdings | 4.17M |
| AXIM Biotechnologies | 3.80M |
| Burzynski Research Institute | 3.42M |
| Orgenesis | 2.95M |
| LakeShore Biopharma | 2.80M |
| Vaccinex | 2.76M |